<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Acute dosing of latrepirdine (Dimebon, dimebolin), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo</title>
	<atom:link href="http://buydimebon.com/news/acute-dosing-of-latrepirdine-dimebon-dimebolin-a-possible-alzheimer-therapeutic-elevates-extracellular-amyloid-beta-levels-in-vitro-and-in-vivo/391/feed/" rel="self" type="application/rss+xml" />
	<link>http://buydimebon.com/news/acute-dosing-of-latrepirdine-dimebon-dimebolin-a-possible-alzheimer-therapeutic-elevates-extracellular-amyloid-beta-levels-in-vitro-and-in-vivo/391/</link>
	<description>Russian Antihistamine Drug to Treat Alzheimer’s Disease</description>
	<pubDate>Sun, 20 May 2012 06:21:48 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
	</channel>
</rss>

